2025年酵素结合免疫吸附检测法全球市场报告

预计未来几年酵素结合免疫吸附检测法市场规模将强劲成长。到 2029 年，这一数字将成长至 38.8 亿美元，复合年增长率为 6.3%。预测期内的成长归因于个人化医疗需求的不断增长、老年人口的不断增长、对早期发现的重视、医疗服务的改善以及对慢性病监测的需求的不断增长。预测期内的关键趋势包括技术进步、对就地检验的需求不断增长、应用领域不断扩大、高通量筛检的采用以及数位 ELISA 的出现。

传染病发生率的上升预计将推动酵素结合免疫吸附检测法(ELISA) 检测市场的成长。由细菌、病毒、真菌、寄生虫等病原微生物引起的感染疾病可以在个体之间传播，并影响身体的各个系统。这些疾病的增加是由于全球旅行增加和抗生素抗药性问题日益严重等因素造成的，这些因素使感染控制工作变得更加复杂。 ELISA 测试在感染疾病管理中很有价值，因为它们可以准确检测和量化与感染疾病相关的特定抗原和抗体，有助于诊断、监测病情进展和评估治疗效果。例如，2024 年 2 月，总部位于瑞士的公共卫生机构世界卫生组织 (WHO) 报告称，2023 年欧洲地区记录了 58,114 例麻疹病例，较 2022 年的 941 例大幅增加。感染疾病的上升正在推动 ELISA 检测市场的成长。

ELISA 检测市场的主要企业正在透过新型 ELISA套件等创新来改进其产品，以提高诊断准确性并满足不同的研究和临床需求。这些先进的 ELISA套件为生物标记检测和定量提供了更高的准确性、灵敏度和易用性。例如，2023 年 2 月，美国製药公司 Charles River Laboratories 推出了一种新型 ELISA 试剂套件，旨在检测和量化基于 CHO 的生物治疗药物中的残留宿主细胞蛋白 (HCP)。此套件使用源自无特定病原体 (SPF) 鸡蛋的禽免疫球蛋白 Y (IgY) 抗体，具有更高的灵敏度和特异性，低检测极限为 0.1 ng/mL，抗体覆盖率为 90%。这项创新旨在加强生物製药开发的品管，确保新治疗方法的安全性和有效性。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、感染疾病、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 全球酵素结合免疫吸附检测法PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
• 最终用途产业分析
• 全球酵素结合免疫吸附检测法市场：成长率分析
• 全球酵素结合免疫吸附检测法市场表现：规模与成长，2019-2024
• 全球酵素结合免疫吸附检测法市场预测：规模与成长，2024-2029 年，2034 年
• 全球酵素结合免疫吸附检测法总目标市场（TAM）

第六章市场区隔

• 全球酵素结合免疫吸附检测法市场类型、效能及预测（2019-2024 年、2024-2029 年及 2034 年）
• 直接酵素免疫分析法（ELISA）
• 夹心酵素免疫分析法（ELISA）
• 酵素免疫分析法（ELISA）
• 多参数、可携式酵素免疫分析法(ELISA)
• 竞争性酵素免疫分析法（ELISA）
• 全球酵素结合免疫吸附检测法市场（依应用、效能及预测），2019-2024 年、2024-2029 年、2034 年
• 免疫学
• 发炎
• 感染疾病
• 癌症
• 蛋白质定量
• 其他用途
• 全球酵素结合免疫吸附检测法市场（依最终使用者、绩效及预测）2019-2024 年、2024-2029 年及 2034 年
• 医院和诊断中心
• 研究部门
• 其他最终用户
• 全球酵素结合免疫吸附检测法市场、直接酵素免疫分析法试验 (ELISA) 细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 单步直接 ELISA
• 竞争性直接 ELISA
• 定量直接 ELISA
• 定性直接 ELISA
• 全球酵素结合免疫吸附检测法市场夹心酵素免疫分析法(ELISA) 细分市场（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 两步夹心 ELISA
• 一步夹心 ELISA
• 定量夹心ELISA
• 定性夹心 ELISA
• 全球酵素结合免疫吸附检测法市场细分（按间接酵素免疫分析法(ELISA) 类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
• 标准间接 ELISA
• 竞争性间接 ELISA
• 定量间接 ELISA
• 定性间接 ELISA

第七章 区域和国家分析

• 全球酵素结合免疫吸附检测法市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 全球酵素结合免疫吸附检测法市场：依国家、地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

• 酵素结合免疫吸附检测法市场：竞争格局
• 酵素结合免疫吸附检测法市场：公司简介
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
  • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

• Agilent Technologies Inc.
• PerkinElmer Inc.
• Bio-Rad Laboratories Inc.
• Tecan Group Ltd.
• GenScript Biotech Corporation
• Promega Corporation
• Abcam plc
• R&D Systems Inc.
• Sino Biological Inc.
• OriGene Technologies Inc.
• RayBiotech Inc.
• Santa Cruz Biotechnology Inc.
• AnaSpec Inc.
• Biomatik
• Arigo Biolaboratories Corp.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

• 2029年酵素结合免疫吸附检测法市场：提供新机会的国家
• 2029年酵素结合免疫吸附检测法市场：细分市场带来新机会
• 2029年酵素结合免疫吸附检测法市场：成长策略
  • 基于市场趋势的策略
  • 竞争对手的策略

第36章 附录

Enzyme-linked immunosorbent assay (ELISA) testing is a widely used laboratory technique designed to detect and quantify specific proteins, antigens, or antibodies in a sample. The method involves immobilizing an antigen or antibody on a solid surface, typically a microplate, and then using enzyme-linked antibodies or antigens to bind to the target molecule.

The main types of ELISA testing include direct enzyme-linked immunosorbent assay (ELISA), sandwich enzyme-linked immunosorbent assay (ELISA), indirect enzyme-linked immunosorbent assay (ELISA), multiple and portable enzyme-linked immunosorbent assays (ELISA), and competitive enzyme-linked immunosorbent assays (ELISA). Direct enzyme-linked immunosorbent assay (ELISA) involves directly immobilizing an antigen on a solid surface. This method can be used for applications in immunology, inflammation, infectious diseases, cancer, protein quantitation, and other areas, serving various end users such as hospitals and diagnostic centers, research laboratories, and more.

The enzyme-linked immunosorbent assay testing market research report is one of a series of new reports from The Business Research Company that provides enzyme-linked immunosorbent assay testing market statistics, including enzyme-linked immunosorbent assay testing industry global market size, regional shares, competitors with an enzyme-linked immunosorbent assay testing market share, detailed enzyme-linked immunosorbent assay testing market segments, market trends and opportunities, and any further data you may need to thrive in the enzyme-linked immunosorbent assay testing industry. This enzyme-linked immunosorbent assay testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The enzyme-linked immunosorbent assay testing market size has grown strongly in recent years. It will grow from $2.85 $ billion in 2024 to $3.04 $ billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to the prevalence of chronic diseases, increased funding and emphasis on biomedical research, approval of ELISA tests by regulatory bodies, government initiatives, and health awareness programs.

The enzyme-linked immunosorbent assay testing market size is expected to see strong growth in the next few years. It will grow to $3.88 $ billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to rising demand for personalized medicine, a growing geriatric population, greater emphasis on early detection, improved access to healthcare services, and a and a growing need for chronic disease monitoring. Major trends in the forecast period include technological advancements, growing demand for point-of-care testing, expanding application areas, the adoption of high-throughput screening, and the emergence of digital ELISA.

The increasing incidence of infectious disorders is expected to drive growth in the enzyme-linked immunosorbent assay (ELISA) testing market. Infectious disorders, caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites, can spread between individuals and affect various body systems. The rise in these disorders is due to factors such as increased global travel and the growing issue of antimicrobial resistance, which complicates infection control efforts. ELISA testing is valuable for managing infectious disorders as it enables precise detection and quantification of specific antigens or antibodies associated with infections, aiding in diagnosis, monitoring disease progression, and assessing treatment effectiveness. For example, in February 2024, the World Health Organization, a Switzerland-based public health organization, reported that 58,114 cases of measles were recorded in the European Region in 2023, a significant increase from 941 cases in 2022. This rising incidence of infectious disorders is thus propelling the growth of the ELISA testing market.

Leading companies in the ELISA testing market are advancing their product offerings with innovations such as novel ELISA kits to enhance diagnostic accuracy and address diverse research and clinical requirements. These advanced ELISA kits offer improved accuracy, sensitivity, and usability for detecting and quantifying biomarkers. For instance, in February 2023, Charles River Laboratories, a US-based pharmaceutical firm, launched a novel ELISA kit designed for detecting and quantifying residual host cell proteins (HCP) in CHO-based biotherapeutics. This kit employs avian immunoglobulin Y (IgY) antibodies derived from specific pathogen-free (SPF) chicken eggs, achieving enhanced sensitivity and specificity with detection limits as low as 0.1 ng/mL and 90% antibody coverage. This innovation aims to enhance quality control in biopharmaceutical development, ensuring the safety and efficacy of new therapies while offering flexibility for client use, either independently or with support from Charles River's experts.

In February 2024, Dyadic International Inc., a biotechnology company based in the US, formed a partnership with Cygnus Technologies to provide a C1 host cell protein (HCP) enzyme-linked immunosorbent assay designed to enhance quality assurance in biomanufacturing. This collaboration centers on quantifying host cell proteins derived from Dyadic's proprietary C1 cells, which utilize the filamentous fungus Thermothelomyces heterothallica. Cygnus Technologies LLC is also a biopharmaceutical company based in the US.

Major companies operating in the enzyme-linked immunosorbent assay testing market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Tecan Group Ltd., GenScript Biotech Corporation, Promega Corporation, Abcam plc, R&D Systems Inc, Sino Biological Inc., OriGene Technologies Inc., RayBiotech Inc., Santa Cruz Biotechnology Inc., AnaSpec Inc., Biomatik, Arigo Biolaboratories Corp., MyBioSource Inc., Boster Biological Technology, Eagle Biosciences Inc., Enzo Life Sciences Inc., StressMarq Biosciences Inc., XpressBio

North America was the largest region in the enzyme-linked immunosorbent assay testing market in 2023. The regions covered in the enzyme-linked immunosorbent assay testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the enzyme-linked immunosorbent assay testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The enzyme-linked immunosorbent assay testing market consists of revenues earned by entities providing services such as diagnostic testing, research and development, detection of antibodies, and vaccine development. The market value includes the value of related goods sold by the service provider or included within the service offering. The enzyme-linked immunosorbent assay testing market also includes sales of ELISA kits, control samples, inhibitor assays, and other consumables such as microplate readers, washers, and automated ELISA systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Enzyme-Linked Immunosorbent Assay Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on enzyme-linked immunosorbent assay testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for enzyme-linked immunosorbent assay testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The enzyme-linked immunosorbent assay testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Direct Enzyme-Linked Immunosorbent Assay (ELISA); Sandwich Enzyme-Linked Immunosorbent Assay (ELISA); Indirect Enzyme-Linked Immunosorbent Assay (ELISA); Multiple And Portable Enzyme-Linked Immunosorbent Assay (ELISA); Competitive Enzyme-Linked Immunosorbent Assay (ELISA)
• 2) By Application: Immunology; Inflammation; Infectious Diseases; Cancer; Protein Quantitation; Other Applications
• 3) By End-User: Hospitals And Diagnostic Centers; Research Laboratories; Other End-Users
• Subsegments:
• 1) By Direct Enzyme-Linked Immunosorbent Assay (ELISA): Single-Step Direct ELISA; Competitive Direct ELISA; Quantitative Direct ELISA; Qualitative Direct ELISA
• 2) By Sandwich Enzyme-Linked Immunosorbent Assay (ELISA): Two-Step Sandwich ELISA; One-Step Sandwich ELISA; Quantitative Sandwich ELISA; Qualitative Sandwich ELISA
• 3) By Indirect Enzyme-Linked Immunosorbent Assay (ELISA): Standard Indirect ELISA; Competitive Indirect ELISA; Quantitative Indirect ELISA; Qualitative Indirect ELISA
• Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA; Siemens Healthineers; Becton Dickinson and Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Enzyme-Linked Immunosorbent Assay Testing Market Characteristics

3. Enzyme-Linked Immunosorbent Assay Testing Market Trends And Strategies

4. Enzyme-Linked Immunosorbent Assay Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Enzyme-Linked Immunosorbent Assay Testing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Enzyme-Linked Immunosorbent Assay Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Enzyme-Linked Immunosorbent Assay Testing Market Growth Rate Analysis
• 5.4. Global Enzyme-Linked Immunosorbent Assay Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Enzyme-Linked Immunosorbent Assay Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Enzyme-Linked Immunosorbent Assay Testing Total Addressable Market (TAM)

6. Enzyme-Linked Immunosorbent Assay Testing Market Segmentation

• 6.1. Global Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Direct Enzyme-Linked Immunosorbent Assay (ELISA)
• Sandwich Enzyme-Linked Immunosorbent Assay (ELISA)
• Indirect Enzyme-Linked Immunosorbent Assay (ELISA)
• Multiple And Portable Enzyme-Linked Immunosorbent Assay (ELISA)
• Competitive Enzyme-Linked Immunosorbent Assay (ELISA)
• 6.2. Global Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immunology
• Inflammation
• Infectious Diseases
• Cancer
• Protein Quantitation
• Other Applications
• 6.3. Global Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Diagnostic Centers
• Research Laboratories
• Other End-Users
• 6.4. Global Enzyme-Linked Immunosorbent Assay Testing Market, Sub-Segmentation Of Direct Enzyme-Linked Immunosorbent Assay (ELISA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Step Direct ELISA
• Competitive Direct ELISA
• Quantitative Direct ELISA
• Qualitative Direct ELISA
• 6.5. Global Enzyme-Linked Immunosorbent Assay Testing Market, Sub-Segmentation Of Sandwich Enzyme-Linked Immunosorbent Assay (ELISA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Two-Step Sandwich ELISA
• One-Step Sandwich ELISA
• Quantitative Sandwich ELISA
• Qualitative Sandwich ELISA
• 6.6. Global Enzyme-Linked Immunosorbent Assay Testing Market, Sub-Segmentation Of Indirect Enzyme-Linked Immunosorbent Assay (ELISA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Standard Indirect ELISA
• Competitive Indirect ELISA
• Quantitative Indirect ELISA
• Qualitative Indirect ELISA

7. Enzyme-Linked Immunosorbent Assay Testing Market Regional And Country Analysis

• 7.1. Global Enzyme-Linked Immunosorbent Assay Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Enzyme-Linked Immunosorbent Assay Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Enzyme-Linked Immunosorbent Assay Testing Market

• 8.1. Asia-Pacific Enzyme-Linked Immunosorbent Assay Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Enzyme-Linked Immunosorbent Assay Testing Market

• 9.1. China Enzyme-Linked Immunosorbent Assay Testing Market Overview
• 9.2. China Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Enzyme-Linked Immunosorbent Assay Testing Market

• 10.1. India Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Enzyme-Linked Immunosorbent Assay Testing Market

• 11.1. Japan Enzyme-Linked Immunosorbent Assay Testing Market Overview
• 11.2. Japan Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Enzyme-Linked Immunosorbent Assay Testing Market

• 12.1. Australia Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Enzyme-Linked Immunosorbent Assay Testing Market

• 13.1. Indonesia Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Enzyme-Linked Immunosorbent Assay Testing Market

• 14.1. South Korea Enzyme-Linked Immunosorbent Assay Testing Market Overview
• 14.2. South Korea Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Enzyme-Linked Immunosorbent Assay Testing Market

• 15.1. Western Europe Enzyme-Linked Immunosorbent Assay Testing Market Overview
• 15.2. Western Europe Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Enzyme-Linked Immunosorbent Assay Testing Market

• 16.1. UK Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Enzyme-Linked Immunosorbent Assay Testing Market

• 17.1. Germany Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Enzyme-Linked Immunosorbent Assay Testing Market

• 18.1. France Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Enzyme-Linked Immunosorbent Assay Testing Market

• 19.1. Italy Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Enzyme-Linked Immunosorbent Assay Testing Market

• 20.1. Spain Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Enzyme-Linked Immunosorbent Assay Testing Market

• 21.1. Eastern Europe Enzyme-Linked Immunosorbent Assay Testing Market Overview
• 21.2. Eastern Europe Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Enzyme-Linked Immunosorbent Assay Testing Market

• 22.1. Russia Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Enzyme-Linked Immunosorbent Assay Testing Market

• 23.1. North America Enzyme-Linked Immunosorbent Assay Testing Market Overview
• 23.2. North America Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Enzyme-Linked Immunosorbent Assay Testing Market

• 24.1. USA Enzyme-Linked Immunosorbent Assay Testing Market Overview
• 24.2. USA Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Enzyme-Linked Immunosorbent Assay Testing Market

• 25.1. Canada Enzyme-Linked Immunosorbent Assay Testing Market Overview
• 25.2. Canada Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Enzyme-Linked Immunosorbent Assay Testing Market

• 26.1. South America Enzyme-Linked Immunosorbent Assay Testing Market Overview
• 26.2. South America Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Enzyme-Linked Immunosorbent Assay Testing Market

• 27.1. Brazil Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Enzyme-Linked Immunosorbent Assay Testing Market

• 28.1. Middle East Enzyme-Linked Immunosorbent Assay Testing Market Overview
• 28.2. Middle East Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Enzyme-Linked Immunosorbent Assay Testing Market

• 29.1. Africa Enzyme-Linked Immunosorbent Assay Testing Market Overview
• 29.2. Africa Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Enzyme-Linked Immunosorbent Assay Testing Market Competitive Landscape And Company Profiles

• 30.1. Enzyme-Linked Immunosorbent Assay Testing Market Competitive Landscape
• 30.2. Enzyme-Linked Immunosorbent Assay Testing Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Enzyme-Linked Immunosorbent Assay Testing Market Other Major And Innovative Companies

• 31.1. Agilent Technologies Inc.
• 31.2. PerkinElmer Inc.
• 31.3. Bio-Rad Laboratories Inc.
• 31.4. Tecan Group Ltd.
• 31.5. GenScript Biotech Corporation
• 31.6. Promega Corporation
• 31.7. Abcam plc
• 31.8. R&D Systems Inc.
• 31.9. Sino Biological Inc.
• 31.10. OriGene Technologies Inc.
• 31.11. RayBiotech Inc.
• 31.12. Santa Cruz Biotechnology Inc.
• 31.13. AnaSpec Inc.
• 31.14. Biomatik
• 31.15. Arigo Biolaboratories Corp.

32. Global Enzyme-Linked Immunosorbent Assay Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Enzyme-Linked Immunosorbent Assay Testing Market

34. Recent Developments In The Enzyme-Linked Immunosorbent Assay Testing Market

35. Enzyme-Linked Immunosorbent Assay Testing Market High Potential Countries, Segments and Strategies

• 35.1 Enzyme-Linked Immunosorbent Assay Testing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Enzyme-Linked Immunosorbent Assay Testing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Enzyme-Linked Immunosorbent Assay Testing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer